Report Detail
Global Generic Injectables Market Insights, Forecast to 2025
- RnM2423799 |
- 14 June, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc.
The global Generic Injectables market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Generic Injectables market based on company, product type, end user and key regions.
This report studies the global market size of Generic Injectables in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Generic Injectables in these regions.
This research report categorizes the global Generic Injectables market by top players/brands, region, type and end user. This report also studies the global Generic Injectables market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Sandoz International
Baxter
Fresenius
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
Lupin Pharmaceuticals
Sanofi
Biocon
Market size by Product
Large Molecule Injectables (Biosimilars)
Small Molecule Injectables
Market size by End User
Oncology
Infectious Diseases
Cardiology
Diabetes
Immunology
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Generic Injectables market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Generic Injectables market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Generic Injectables companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Generic Injectables submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Generic Injectables are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Generic Injectables market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Generic Injectables Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Generic Injectables Market Size Growth Rate by Product
- 1.4.2 Large Molecule Injectables (Biosimilars)
- 1.4.3 Small Molecule Injectables
- 1.5 Market by End User
- 1.5.1 Global Generic Injectables Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Infectious Diseases
- 1.5.4 Cardiology
- 1.5.5 Diabetes
- 1.5.6 Immunology
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Generic Injectables Market Size
- 2.1.1 Global Generic Injectables Revenue 2014-2025
- 2.1.2 Global Generic Injectables Sales 2014-2025
- 2.2 Generic Injectables Growth Rate by Regions
- 2.2.1 Global Generic Injectables Sales by Regions
- 2.2.2 Global Generic Injectables Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Generic Injectables Sales by Manufacturers
- 3.1.1 Generic Injectables Sales by Manufacturers
- 3.1.2 Generic Injectables Sales Market Share by Manufacturers
- 3.1.3 Global Generic Injectables Market Concentration Ratio (CR5 and HHI)
- 3.2 Generic Injectables Revenue by Manufacturers
- 3.2.1 Generic Injectables Revenue by Manufacturers (2014-2019)
- 3.2.2 Generic Injectables Revenue Share by Manufacturers (2014-2019)
- 3.3 Generic Injectables Price by Manufacturers
- 3.4 Generic Injectables Manufacturing Base Distribution, Product Types
- 3.4.1 Generic Injectables Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Generic Injectables Product Type
- 3.4.3 Date of International Manufacturers Enter into Generic Injectables Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Generic Injectables Sales by Product
- 4.2 Global Generic Injectables Revenue by Product
- 4.3 Generic Injectables Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Generic Injectables Breakdown Data by End User
6 North America
- 6.1 North America Generic Injectables by Countries
- 6.1.1 North America Generic Injectables Sales by Countries
- 6.1.2 North America Generic Injectables Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Generic Injectables by Product
- 6.3 North America Generic Injectables by End User
7 Europe
- 7.1 Europe Generic Injectables by Countries
- 7.1.1 Europe Generic Injectables Sales by Countries
- 7.1.2 Europe Generic Injectables Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Generic Injectables by Product
- 7.3 Europe Generic Injectables by End User
8 Asia Pacific
- 8.1 Asia Pacific Generic Injectables by Countries
- 8.1.1 Asia Pacific Generic Injectables Sales by Countries
- 8.1.2 Asia Pacific Generic Injectables Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Generic Injectables by Product
- 8.3 Asia Pacific Generic Injectables by End User
9 Central & South America
- 9.1 Central & South America Generic Injectables by Countries
- 9.1.1 Central & South America Generic Injectables Sales by Countries
- 9.1.2 Central & South America Generic Injectables Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Generic Injectables by Product
- 9.3 Central & South America Generic Injectables by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Generic Injectables by Countries
- 10.1.1 Middle East and Africa Generic Injectables Sales by Countries
- 10.1.2 Middle East and Africa Generic Injectables Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Generic Injectables by Product
- 10.3 Middle East and Africa Generic Injectables by End User
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Pfizer Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Pfizer Generic Injectables Products Offered
- 11.1.5 Pfizer Recent Development
- 11.2 Sandoz International
- 11.2.1 Sandoz International Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sandoz International Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sandoz International Generic Injectables Products Offered
- 11.2.5 Sandoz International Recent Development
- 11.3 Baxter
- 11.3.1 Baxter Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Baxter Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Baxter Generic Injectables Products Offered
- 11.3.5 Baxter Recent Development
- 11.4 Fresenius
- 11.4.1 Fresenius Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Fresenius Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Fresenius Generic Injectables Products Offered
- 11.4.5 Fresenius Recent Development
- 11.5 Mylan
- 11.5.1 Mylan Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Mylan Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Mylan Generic Injectables Products Offered
- 11.5.5 Mylan Recent Development
- 11.6 Teva Pharmaceutical
- 11.6.1 Teva Pharmaceutical Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Teva Pharmaceutical Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Teva Pharmaceutical Generic Injectables Products Offered
- 11.6.5 Teva Pharmaceutical Recent Development
- 11.7 Hikma Pharmaceuticals
- 11.7.1 Hikma Pharmaceuticals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Hikma Pharmaceuticals Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Hikma Pharmaceuticals Generic Injectables Products Offered
- 11.7.5 Hikma Pharmaceuticals Recent Development
- 11.8 Lupin Pharmaceuticals
- 11.8.1 Lupin Pharmaceuticals Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Lupin Pharmaceuticals Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Lupin Pharmaceuticals Generic Injectables Products Offered
- 11.8.5 Lupin Pharmaceuticals Recent Development
- 11.9 Sanofi
- 11.9.1 Sanofi Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Sanofi Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Sanofi Generic Injectables Products Offered
- 11.9.5 Sanofi Recent Development
- 11.10 Biocon
- 11.10.1 Biocon Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Biocon Generic Injectables Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Biocon Generic Injectables Products Offered
- 11.10.5 Biocon Recent Development
12 Future Forecast
- 12.1 Generic Injectables Market Forecast by Regions
- 12.1.1 Global Generic Injectables Sales Forecast by Regions 2019-2025
- 12.1.2 Global Generic Injectables Revenue Forecast by Regions 2019-2025
- 12.2 Generic Injectables Market Forecast by Product
- 12.2.1 Global Generic Injectables Sales Forecast by Product 2019-2025
- 12.2.2 Global Generic Injectables Revenue Forecast by Product 2019-2025
- 12.3 Generic Injectables Market Forecast by End User
- 12.4 North America Generic Injectables Forecast
- 12.5 Europe Generic Injectables Forecast
- 12.6 Asia Pacific Generic Injectables Forecast
- 12.7 Central & South America Generic Injectables Forecast
- 12.8 Middle East and Africa Generic Injectables Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Generic Injectables Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Generic Injectables . Industry analysis & Market Report on Generic Injectables is a syndicated market report, published as Global Generic Injectables Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Generic Injectables market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
